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Background:  Pain at the site of rocuronium injection is a common side-effect in pediatric patients.  This prospective, 
randomized, double-blind study evaluated the efficacy of a combination of nitrous oxide and lidocaine pretreatment 
on withdrawal response during rocuronium injection in children.
Methods:  Sixty six pediatric patients, ages 5 to 12 years, were randomly assigned to two groups.  The oxygen group 
received 100% oxygen, and the nitrous oxide group received 50% N2O in oxygen over 2 min.  After anesthesia was 
induced with 2.5% thiopental sodium 5 mg/kg and manual occlusion of the forearm was performed, 1% lidocaine 
1 mg/kg was injected over 15 sec.  After the occlusion was released, 0.1% rocuronium 0.6 mg/kg was injected over 5 
sec. Patient response to rocuronium injection was graded using a 4-point scale.
Results:  Overall incidence of withdrawal movements was significantly lower in the nitrous oxide group (1 patients; 
3.1%) than in the oxygen group (8 patients; 25.8%) (P = 0.013).  No patient in the nitrous oxide group displayed arm or 
generalized movement (grade 3 or 4) associated with rocuronium injection. 
Conclusions:  This study demonstrated that a combination of inhaled 50% N2O in O2 and 1 mg/kg lidocaine 
pretreatment significantly reduced the incidence of rocuronium-induced withdrawal movements in pediatric 
patients compared with lidocaine pretreatment alone.  (Korean J Anesthesiol 2010; 58: 446-449)
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Introduction
    Pain is a common side-effect reported by 50-80% of patients 
receiving rocuronium injection [1-3]. Severe withdrawal 
movements tend to occur more frequently in pediatric patients, 
possibly because small veins take longer to clear. It can be 
a troublesome situation when sudden flexion of wrist and 
elbow, or other generalized movement occurs during injection 
of rocuronium. Several methods have been applied in an 
attempt to decrease the incidence of withdrawal movement in 
children. These include lidocaine [3], ketamine [4], or opioid 
[5,6] injection prior to rocuronium injection. These, however, 
do not completely eliminate withdrawal movement in all cases. 
Nitrous oxide is a well-established, centrally-acting sedative 
and analgesic agent. However, use of nitrous oxide to reduce 
withdrawal movement after rocuronium in children has not 447 www.ekja.org
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been reported. Therefore, this prospective, randomized study 
evaluated the efficacy of a combination of nitrous oxide and 
lidocaine pretreatment on the withdrawal response during 
rocuronium injection in children.
Materials and Methods
    This study was approved by the institutional review board, 
and informed parental consent was obtained. The study was 
conducted prospectively on 66 patients between the ages of 
5 and 12 years, with ASA physical status I or II, undergoing 
general anesthesia for elective surgery. Patients with known 
allergy to local anesthetics, asthma, neurologic deficits, those 
receiving analgesics or sedatives within the previous 24 
hours, or those crying on arrival in the operating room were 
excluded from this study. Three children were excluded due to 
crying and one due to failure of IV access. No premedication 
was administered before surgery. Before arriving at the 
operating room, a 22 or 24-gauge cannula was inserted in 
the dorsum of the hand, and its position was confirmed by 
the free flow of a dextrose/saline infusion by gravity. Upon 
arrival at the operating room, all patients were monitored 
with electrocardiogram, pulse oxymeter, non-invasive arterial 
pressure, and capnography. Patients were randomly assigned 
to two groups using a computer generated randomization table. 
Patients in the oxygen group (n = 33) were preoxygenated with 
100% oxygen. Patients in the nitrous oxide group (n = 33) were 
preoxygenated with 50% N2O mixture in oxygen. The fresh gas 
flow was set at 6 L/min. Study gases were administrated with a 
face mask gently held on the patients’ face, but with an effective 
seal. Patients in both groups were asked to breathe normally 
via a face mask for 2 min prior to induction. In both groups, 
anesthesia was induced with 2.5% thiopental sodium 5 mg/kg 
followed by a free flow of IV fluid until loss of consciousness. 
Thirty seconds later, manual occlusion of the forearm was 
per  formed with sufficient force to stop IV flow by gravity, and 
1% lidocaine 1 mg/kg was injected over 15 sec while manual 
forearm pressure was maintained, then released, followed by 
injection of 0.1% rocuronium 0.6 mg/kg over 5 sec. Assisted 
mask venti  lation with O2 (or mixture of O2 and N2O) was applied 
if desaturation was observed (SpO2 < 90%). All medications 
were injected into a port connected directly to the IV catheter 
while the IV tubing was clamped above the injection site. After 
injection of rocuronium, fluids were administrated at a gravity 
flow. No visible precipitation occurred in the transparent 
portion of the IV tubing. Patients, anesthesia providers, and 
investigators who scored the movements were blind to the gas 
mixture administered to patients (flowmeters were covered by 
cardboard). Patient response was graded by the investigator 
according to the scale proposed by Shevchenko et al. [3], as 
follows: 1 = no response, 2 = movement at the wrist only, 3 = 
movement/withdrawal involving arm only (elbow/shoulder), 
and 4 = generalized response, movement/withdrawal in more 
than one extremity. The investigator also recorded the incidence 
of coughing and breath holding. Once responses were graded, 
the study was terminated. Anesthesia was continued based on 
the decision of the anesthetist. 
    From previous studies [3], rocuronium induced-withdrawal 
movement after pretreatment with lidocaine was expected to 
be approximately 45%. Therefore, 30 subjects per group would 
be needed to decrease this incidence to 10% (power 80% and 
α = 0.05). The sample size was increased to 66 patients on 
assumption of a 10% dropout rate. Statistical analyses were 
performed using the statistical package (SPSS 13.0 for windows, 
SPSS Inc, Chicago, IL, USA). Data are presented as mean ± SD 
or number of patients. Patient characteristics were compared 
with Student’s t-test or Fisher’s exact test where appropriate. 
Incidence of withdrawal movement was analyzed with Fisher’s 
exact test. A P value < 0.05 was considered significant.
Results
    A total of 66 patients were initially enrolled in the study. One 
patient in the nitrous oxide group became excited and started 
crying, and two patients in the oxygen group did not complete 
the study due to unwillingness to cooperate. Hence, data for 63 
patients is presented. No significant difference was observed in 
patient characteristics between the two groups (Table 1).
Table 1.  Patient Characteristics
O2
(n = 31)
N2O
(n = 32)
Sex (M/F)
Age (yr)
Weight (kg)
ASA physical status (I/II) (n)
Cannula size (22/24-gauge) (n) 
18/13
7.7 ± 2.3
26.1 ± 8.4
26/5
13/18
16/16
7.1 ± 1.7
26.0 ± 7.6
28/4
15/17
Values are mean ± SD or number of patients.  No significant differ-
ences between the two groups were noted.
Table 2.  Incidence and Grade of Withdrawal Movements Associated 
with Rocuronium Injection
Grade of withdrawal movements
O2 
(n = 31)
N2O 
(n = 32)
1 (No withdrawal)
2 (Wrist withdrawal)
3 (Arm only)
4 (Generalized movement)
23 (74.1)
2 (6.5)
  4 (12.9)
 2 (6. 5)
 31 (96.9)*
1 (3.1)
0 (0.0)
0 (0.0)
Values are number of patients (percentage).  *P < 0.05 compared with 
group O2.448 www.ekja.org
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    Incidence and grade of withdrawal movement are listed 
in Table 2. Overall incidence of withdrawal movements was 
significantly lower in the nitrous oxide group (1 patients; 3.1%) 
than in the oxygen group (8 patients; 25.8%) (P = 0.013). In 
the oxygen group, 4 and 2 patients showed arm withdrawal 
movement (grade 3) and generalized movement (grade 4), 
respectively. None of the patients in the nitrous oxide group 
displayed arm or generalized movement (grade 3 or 4) 
associated with rocuronium injection. There were no significant 
differences in the SpO2 between the two groups, and SpO2 
remained above 90% throughout the study period.
Discussion
    This study demonstrated that a combination of inhaled 50% 
N2O in O2 mixture and pretreatment of 1 mg/kg lidocaine 
significantly reduced the incidence of rocuronium-induced 
withdrawal movements in pediatric patients compared with 
lidocaine pretreatment alone.
    The need to reduce withdrawal movement or pain during 
rocuronium injection has encouraged a number of different 
approaches using local anaesthetics, opioids, sodium bicar-
bonate and many other drugs [3-10]. Among these, one of the 
most popular methods is the pretreatment of lidocaine with or 
without tourniquet technique, as in propofol injection pain [11]. 
However, even using lidocaine, the incidence of rocuronium 
induced-withdrawal movements or pain has been reported 
to between 46% and 17.5% [3,7-10]. Incidence of withdrawal 
movement in our study, following lidocaine pretreatment 
alone was 25.8%, comparable findings from previous studies. 
Furthermore, incidence of withdrawal movements decreased to 
3.1%, in addition to inhalation of 50% N2O mixture over 2 min, 
as well as lidocaine pretreatment. The central antinociceptive 
effects of nitrous oxide may prevent the pain that results from 
the local irritant effect of rocuronium [12]. N2O has been used as 
an analgesic and as an anesthesia, and is still widely used today. 
N2O has been reported to affect a variety of different receptors, 
including opioid [13], noradrenergic [14], acetylcholine [15], 
γ-aminobutyric acid (GABA) [16], and N-methyl-d-aspartate 
(NMDA) [17] receptors. However, the mechanisms underlying 
its unique pharmacodynamic profile have not yet been fully 
clarified. Moreover, it is believed that the different effects of N2O 
(analgesic, anxiolytic, amnestic, hallucinogenic, and sedative, 
among others) are mediated by different pathways. Opioid 
receptors in the periaqueductal gray, noradrenergic descending 
inhibitory pathways, and inhibitory interneurons in the spinal 
cord [18] are thought to be involved in the analgesic action of 
N2O. Because N2O-induced analgesic action could be indirectly 
achieved through mediation by different pathways, exposure 
time to N2O in this study (<5 min) may be insufficient for 
production of an adequate analgesic effect. Therefore, further 
study for elucidation of the analgesic effect of N2O might be 
needed.
    On the other hand, the effect of lidocaine was more likely the 
result of local anesthetic effect at the site of injection, due to the 
fact that venous occlusion technique was applied to the forearm 
over 15 sec from time of injection of lidocaine until rocuronium 
was injected. Therefore, a limited amount of lidocaine injected 
reached systemic circulation. Ahmad et al. [9] suggested that 
the central analgesic effect of a drug is only effective if adequate 
time is allowed for onset of analgesia, whereas pretreatment 
with drugs having local anesthetic properties is effective when 
administered immediately before, or with a venous occlusion 
technique.
    A high concentration of N2O, such as 70%, may cause side 
effects including excitement, dysphoria, nausea, restlessness 
and opisthotonic movements [19]. Concentrations of 15-
45% N2O produce quantifiable and meaningful increases in 
the threshold for both sensation and tolerance of pain. At con  -
centrations below 50%, the analgesic effect of N2O follows 
a linear dose response pattern [20], although cognitive and 
other psychological factors also have an influence. As a result, 
we chose to use a concentration of 50% N2O. In addition, 
we enrolled children older than 5 years because it was our 
experience that these children could perform tidal volume 
breath with masks on their faces. N2O is widely available, easy 
to administer, and relatively free of side effects, bringing it to 
the useful analgesic agent in pediatric patients. Nevertheless, 
in our study, one patient in the nitrous oxide group developed 
side effects that included excitement and crying. Although 
the effect of N2O can be quickly reversed by stopping the N2O, 
and the complication of inhaled N2O may be brief and benign, 
the possibility of this complication occurring with the use of 
N2O must be considered. Another potential concern with the 
use of N2O during induction would be unanticipated difficult 
airway and compromised preoxygenation. Although, previous 
study has found that preoxygenation with mixtures of oxygen 
and N2O can help to smooth induction without impairment of 
oxygenation [21], care should be taken for possible desaturation 
during anesthetic induction in children. 
    In conclusion, pretreatment of two different analgesic 
modalities, nitrous oxide and lidocaine, prevents withdrawal 
movement grade 3 and 4 (arm only and generalized movement) 
associated with rocuronium injection, and reduces overall 
incidence of withdrawal movement in children. 
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